Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 7:14:33.
doi: 10.1186/s13027-019-0253-6. eCollection 2019.

A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh

Affiliations
Review

A meta-analysis on genetic variability of RT/HBsAg overlapping region of hepatitis B virus (HBV) isolates of Bangladesh

Md Golzar Hossain et al. Infect Agent Cancer. .

Abstract

Background and aim: Hepatitis B caused by HBV is a serious public health hazard prevalent worldwide including Bangladesh. Few scattered molecular studies of HBV have been reported in Bangladesh. This study aimed to analyze the genetic variability of RT/HBsAg overlapping region of HBV isolates of Bangladesh and determination of correlation among the genotype/serotype and HBsAg escape and/or drug-resistant mutations.

Methods: A total of 97 complete HBsAg sequences of Bangladeshi HBV isolates from 2005 to 2017 from NCBI GenBank were extracted and analyzed using several HBV bioinformatics tools such as Geno2pheno-HBV, HBV Serotyper, HIV-Grade:HBV-Tool, and CLC sequence viewer.

Results: The prevalence of genotypes A, C, and D are 18, 46 and 35% which correspond to serotype adw, adr, and ayw, respectively. The prevalence of HBsAg escape mutations is 51% and most of which (62%) are found in the genotype D followed by 32% in genotype C and 6% in genotype A. Interestingly most (24/36) of the sequences of HBsAg escape mutations contained 128 V mutant which all belongs to only serotype ayw3 (Genotype D). Prevalence of drug-resistant mutations is ~ 11%, most of which are from genotype C (63.64%) and D (36.36%). Lamivudine resistant mutations were found in ~ 11% of sequences followed by Telbivudine 10% and Adefovir 3% where Tenofovir showed susceptibility to all 97 sequences. Moreover, 7 among of 97 sequences showed both HBsAg and drugs resistant mutations and none of them are found due to the same nucleotide substitutions.

Conclusion: There is a strong correlation among the genotype/serotype and HBsAg escape and/or drug-resistant mutations. This meta-analytical review will be helpful for genotype-serotype prediction by PCR-based diagnosis and development of vaccine and/or diagnostic kits, and the treatment against HBV infection in the future.

Keywords: Bangladesh; Drug-resistant mutations; Genotype; HBsAg escape mutations; Hepatitis B virus (HBV); Serotype.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Prevalence of HBV genotype and serotype. Ninety-seven complete small HBsAg coding sequences of Bangladeshi HBV isolates of year, 2005–2017 were collected from NCBI GenBank. The HBV genotype and serotype were re-determined by using the bioinformatics tool followed by an analysis of their overall prevalence of genotype (a) and serotype (b) circulating in Bangladesh. Chi-square test was performed to determine the statistical significance level and only the p-value greater than 0.05 was mentioned
Fig. 2
Fig. 2
Distribution of HBV genotype among the serotype. Relationship of HBV genotype and serotype of Bangladeshi HBV isolates from 2005 to 2017 was determined. Chi-square test was performed to determine the statistical significance level and only the p-value greater than 0.05 was mentioned
Fig. 3
Fig. 3
Prevalence of HBsAg escape and drug-resistant mutations in RT/HBsAg overlapping region. Mutations related to HBsAg escape and drug resistant of RT/HBsAg overlapping region were determined by using Geno2pheno-HBV and HIV Grade: HBV-Tool. a Overall prevalence of HBsAg escape (a) and drug-resistant mutations (b) circulating in Bangladesh from 2005 to 2017 determined by two different bioinformatics tools. c Specific mutations with their frequency related to HBsAg escape and drug-resistant in the RT/HBsAg overlapping region. The numbers within the bracket showed the frequency of that mutation
Fig. 4
Fig. 4
Distribution (Relationship) of HBsAg escape and drug-resistant mutations among the genotypes. Relationship of HBsAg escape and drug-resistant HBV mutations circulating in Bangladesh from 2005 to 2017 was determined (a and b). Chi-square test was performed to determine the statistical significance level and only the p-value greater than 0.05 was mentioned
Fig. 5
Fig. 5
Alignment of the nucleotide sequences (a) and amino acid sequences of HBsAg, (b) and Pol RT domain (c) of the sequences showed both HBsAg escape and drug-resistant mutations

Similar articles

Cited by

References

    1. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292(15):771–774. doi: 10.1056/NEJM197504102921503. - DOI - PubMed
    1. Gray Davis L, Weber D, Lemon S. HORIZONTAL TRANSMISSION OF HEPATITIS B VIRUS. Lancet. 1989;333(8643):889–893. doi: 10.1016/S0140-6736(89)92876-6. - DOI - PubMed
    1. Romeo R, Petruzziello A, Pecheur EI, Facchetti F, Perbellini R, Galmozzi E, Khan NU, Di Capua L, Sabatino R, Botti G, et al. Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiol Infect. 2018;146(13):1612–1618. doi: 10.1017/S0950268818001942. - DOI - PMC - PubMed
    1. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat. 1997;4(Suppl 1):11–20. doi: 10.1111/j.1365-2893.1997.tb00155.x. - DOI - PubMed
    1. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995;38(1–2):24–34. doi: 10.1159/000150411. - DOI - PubMed